Ackman: Why I’m Electing Stock in Allergan Deal

April 23 (Bloomberg) -- Bill Ackman, CEO at Pershing Square Capital, discusses teaming with Valeant Pharmaceuticals to purchase Allergan on Bloomberg Television’s “Market Makers.”
Senator Reid Won’t Run Again
44:54 - Bloomberg’s Matt Miller reports on today’s top news stories. He speaks on “Market Makers.” (Source: Bloomberg)
  • What Scottish Businesses Want Ahead of the Election
  • Investing in ETFs With Futuristic Themes
  • Consumer Confidence Falls Less Than Expected